Optimization of EKG Method for Long Term Central Venous Catheter Tip Placement

NCT ID: NCT01763801

Last Updated: 2013-01-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

326 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-07-31

Study Completion Date

2012-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Intravenous electrocardiographic guidance (IVECG) is a safe, reliable and accurate technique to correctly position the catheter tip. The investigators sought to evaluate the superiority of the P-maximal (P-max) wave compared to the P-submaximal (P-submax) wave in obtaining a more correct, safer and longer lasting device placement, with a lower incidence of complications and secondary misplacement.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This prospective randomized trial was designed to observe the placement of long term iv catheters obtained with the IVECG method. Patients were randomised into 2 groups: in group A the catheter tip was placed in correspondence to the P-max, in group B in correspondence to the P-submax. We followed up the tip position by measuring the variation of its distances from the tracheal carina on multiplanar reconstructions of volumetric CT scans taken within a month (T0) and a year (T1) from the port implant.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vascular Access Complication

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

P-Max group

Includes cases in which the catheter tip was considered correctly positioned when the Maximal P wave was obtained

Group Type ACTIVE_COMPARATOR

P-Max

Intervention Type DEVICE

tip placement in correspondence to the P-Max on the ECG

P-Submax group

Includes cases in which the catheter tip was considered correctly positioned when the Submaximal P wave was obtained

Group Type ACTIVE_COMPARATOR

P-Submax

Intervention Type DEVICE

tip placement in correspondence to the P-Submax on the ECG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

P-Max

tip placement in correspondence to the P-Max on the ECG

Intervention Type DEVICE

P-Submax

tip placement in correspondence to the P-Submax on the ECG

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* indication to chemo port insertion
* ability to give informed consent

Exclusion Criteria

* younger than 18
* inability to give consent
* atrial fibrillation or flutter
* pace-maker or implantable cardioverter-defibrillator
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Campus Bio-Medico University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Massimiliano Carassiti

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Massimiliano Carassiti, Professor

Role: PRINCIPAL_INVESTIGATOR

Campus Bio-Medico University

Paola Proscia, Doctor

Role: PRINCIPAL_INVESTIGATOR

Campus Bio-Medico University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital Campus BioMedico

Rome, , Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CaraPros

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.